EMEA Releases Guidelines On Development Of Medicines For Alzheimer’s Disease And Parkinson’s Disease

Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

The European Medicines Agency (EMEA) has released two guidelines for companies developing medicines for the treatment of Alzheimer’s disease and other dementias, and for Parkinson’s disease, in the light of recent scientific progress in the understanding of these diseases and conditions. Advances in clinical science, physiopathology and molecular biology have stimulated new interest in the development of more effective symptomatic or disease-modifying treatments, i.e.

More: continued here









Leave a Reply